|Articles|September 23, 2014
Clinical Trial Experts Respond to Negative Toronto Sun Article
Author(s)Lisa Henderson
President and Co-founder of Canadian CRO Scimega Research, Denise Deakin, addresses last week's article published in the Toronto Star
Advertisement
In this blog
, President and Co-founder of Canadian CRO Scimega Research, Denise Deakin addresses last week's article published in the Toronto Star regarding lax oversight of clinical trials in Canada. Ms. Deakin outlines the seriousness of the charges, however, believes that the public should view this information in the proper context and "be made aware of what percentage this represents out of the entire clinical research spectrum across the country."
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
3
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
4
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
5